
Cervical cancer screening — one of medicine’s greatest success stories — has reduced cervical cancer mortality by more than 70% in countries with effective programs. The combination of Pap smear (cytological examination of cervical cells) and HPV (human papillomavirus) co-testing provides highly sensitive and specific detection of precancerous changes and early cancer. This guide expands on how clinics conduct comprehensive cervical cancer screening beyond the basic Pap smear discussion.
Why HPV Testing Matters
Human papillomavirus causes virtually all cervical cancers. Of the many HPV types, HPV 16 and 18 are responsible for approximately 70% of cervical cancers. HPV co-testing with the Pap smear significantly improves the sensitivity of cervical screening — a negative HPV test provides greater reassurance than a negative Pap alone, justifying extended screening intervals (every 5 years for co-testing versus every 3 years for Pap alone). HPV primary testing (without simultaneous Pap smear) is an increasingly accepted alternative screening strategy for women ages 25 and older.
The Colposcopy Referral
When cervical screening results are abnormal, colposcopy — a magnified visual examination of the cervix using a colposcope, with application of acetic acid to highlight abnormal areas — guides directed biopsies of concerning regions. Colposcopy histology classifies lesions as CIN 1 (mild dysplasia — usually monitored), CIN 2 (moderate dysplasia — usually treated), or CIN 3/CIS (severe dysplasia/carcinoma in situ — requires treatment).
Treatment of Precancerous Lesions
High-grade cervical dysplasia (CIN 2 and 3) is treated with LEEP (loop electrosurgical excision procedure) or cone biopsy — removing the abnormal tissue zone from the cervix under local anesthesia. These outpatient procedures prevent cervical cancer by removing the precancerous tissue before cancer develops.
Conclusion
Cervical cancer is preventable — through HPV vaccination in adolescence and early adulthood, combined with consistent cervical screening according to recommended guidelines throughout adult life. Every woman who follows these recommendations dramatically reduces her risk of developing and dying from cervical cancer. Make cervical screening a non-negotiable component of your routine healthcare.
FAQs – Cervical Cancer Screening
Q1. What is CIN and is it cancer?
A: CIN (cervical intraepithelial neoplasia) refers to precancerous changes in cervical cells. CIN 1 is mild and often resolves spontaneously. CIN 2 and 3 are higher-grade precancerous changes that require treatment to prevent progression to invasive cancer. CIN is not yet cancer but left untreated, CIN 3 progresses to invasive cancer in a significant proportion of cases.
Q2. Can I get HPV even after vaccination?
A: The 9-valent HPV vaccine (Gardasil 9) covers the 9 most important high-risk and low-risk HPV types. It does not cover all HPV types — screening remains important even after vaccination. However, vaccinated individuals are protected against the HPV types causing 90% of cervical cancers and genital warts.
Q3. Does HPV always cause cervical abnormalities?
A: No. HPV infection is extremely common (nearly all sexually active people are infected at some point), and most infections clear spontaneously without causing any cellular changes. Persistent infection with high-risk HPV types is what causes cervical precancer and cancer over many years.
Q4. How long after LEEP treatment do I need follow-up?
A: Following LEEP for high-grade CIN, intensive follow-up with Pap/HPV co-testing at 6, 12, and 24 months is recommended. If all follow-up tests are negative, you can return to standard screening intervals. Positive follow-up tests require colposcopy.
Q5. Does anal cancer also involve HPV screening?
A: Anal cancer is caused by HPV (primarily HPV 16) and occurs predominantly in men who have sex with men and HIV-positive individuals. Anal Pap smear screening and high-resolution anoscopy are performed at some specialized clinics for high-risk populations, though universal anal cancer screening guidelines do not yet exist.